189 related articles for article (PubMed ID: 23635656)
1. ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.
Liu X; Lu M; Tang L; Zhang N; Chui D; Fan D
Neurobiol Aging; 2013 Sep; 34(9):2236.e5-8. PubMed ID: 23635656
[TBL] [Abstract][Full Text] [Related]
2. Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2.
Tazen S; Figueroa K; Kwan JY; Goldman J; Hunt A; Sampson J; Gutmann L; Pulst SM; Mitsumoto H; Kuo SH
JAMA Neurol; 2013 Oct; 70(10):1302-4. PubMed ID: 23959108
[TBL] [Abstract][Full Text] [Related]
3. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
[TBL] [Abstract][Full Text] [Related]
4. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.
Neuenschwander AG; Thai KK; Figueroa KP; Pulst SM
JAMA Neurol; 2014 Dec; 71(12):1529-34. PubMed ID: 25285812
[TBL] [Abstract][Full Text] [Related]
5. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
Van Damme P; Veldink JH; van Blitterswijk M; Corveleyn A; van Vught PW; Thijs V; Dubois B; Matthijs G; van den Berg LH; Robberecht W
Neurology; 2011 Jun; 76(24):2066-72. PubMed ID: 21562247
[TBL] [Abstract][Full Text] [Related]
6. Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.
Kim YE; Oh KW; Noh MY; Park J; Kim HJ; Park JE; Ki CS; Kim SH
Neurobiol Aging; 2018 Jul; 67():201.e5-201.e8. PubMed ID: 29665996
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous ALS and SCA2 associated with an intermediate-length
Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
[TBL] [Abstract][Full Text] [Related]
8. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
[TBL] [Abstract][Full Text] [Related]
9. ATXN-2 CAG repeat expansions are interrupted in ALS patients.
Corrado L; Mazzini L; Oggioni GD; Luciano B; Godi M; Brusco A; D'Alfonso S
Hum Genet; 2011 Oct; 130(4):575-80. PubMed ID: 21537950
[TBL] [Abstract][Full Text] [Related]
10. Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis.
Daoud H; Belzil V; Martins S; Sabbagh M; Provencher P; Lacomblez L; Meininger V; Camu W; Dupré N; Dion PA; Rouleau GA
Arch Neurol; 2011 Jun; 68(6):739-42. PubMed ID: 21670397
[TBL] [Abstract][Full Text] [Related]
11. Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS--a systematic review and meta-analysis of observational studies.
Wang MD; Gomes J; Cashman NR; Little J; Krewski D
PLoS One; 2014; 9(8):e105534. PubMed ID: 25148523
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CACNA1A CAG repeat lengths in patients with familial ALS.
Brenner D; Müller K; Gastl R; Gorges M; Otto M; Pinkhardt EH; Kassubek J; Weishaupt JH; Ludolph AC
Neurobiol Aging; 2019 Feb; 74():235.e5-235.e8. PubMed ID: 30342765
[TBL] [Abstract][Full Text] [Related]
13. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
[TBL] [Abstract][Full Text] [Related]
14. Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis.
Chen Y; Huang R; Yang Y; Chen K; Song W; Pan P; Li J; Shang HF
Neurobiol Aging; 2011 Oct; 32(10):1925.e1-5. PubMed ID: 21741123
[TBL] [Abstract][Full Text] [Related]
15. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
Bäumer D; East SZ; Tseu B; Zeman A; Hilton D; Talbot K; Ansorge O
Acta Neuropathol; 2014 Oct; 128(4):597-604. PubMed ID: 24718895
[TBL] [Abstract][Full Text] [Related]
16. ATXN2 trinucleotide repeat length correlates with risk of ALS.
Sproviero W; Shatunov A; Stahl D; Shoai M; van Rheenen W; Jones AR; Al-Sarraj S; Andersen PM; Bonini NM; Conforti FL; Van Damme P; Daoud H; Del Mar Amador M; Fogh I; Forzan M; Gaastra B; Gellera C; Gitler AD; Hardy J; Fratta P; La Bella V; Le Ber I; Van Langenhove T; Lattante S; Lee YC; Malaspina A; Meininger V; Millecamps S; Orrell R; Rademakers R; Robberecht W; Rouleau G; Ross OA; Salachas F; Sidle K; Smith BN; Soong BW; Sorarù G; Stevanin G; Kabashi E; Troakes C; van Broeckhoven C; Veldink JH; van den Berg LH; Shaw CE; Powell JF; Al-Chalabi A
Neurobiol Aging; 2017 Mar; 51():178.e1-178.e9. PubMed ID: 28017481
[TBL] [Abstract][Full Text] [Related]
17. Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis.
Lu HP; Gan SR; Chen S; Li HF; Liu ZJ; Ni W; Wang N; Wu ZY
Neurobiol Aging; 2015 Mar; 36(3):1603.e11-4. PubMed ID: 25457026
[TBL] [Abstract][Full Text] [Related]
18. Investigating
Jih KY; Lin KP; Tsai PC; Soong BW; Liao YC; Lee YC
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):442-447. PubMed ID: 33377399
[TBL] [Abstract][Full Text] [Related]
19. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
[TBL] [Abstract][Full Text] [Related]
20. De novo mutations in ataxin-2 gene and ALS risk.
Laffita-Mesa JM; Rodríguez Pupo JM; Moreno Sera R; Vázquez Mojena Y; Kourí V; Laguna-Salvia L; Martínez-Godales M; Valdevila Figueira JA; Bauer PO; Rodríguez-Labrada R; González Zaldívar Y; Paucar M; Svenningsson P; Velázquez Pérez L
PLoS One; 2013; 8(8):e70560. PubMed ID: 23936447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
